...
机译:用响应Poziotinib的激活EGFR外显子20插入突变成功治疗粟粒转移性NSCLC患者
Kunming Med Univ Affiliated Dehong Peoples Hosp Dept Pharm Dehong Yunnan Peoples R China;
Kunming Med Univ Affiliated Dehong Peoples Hosp Dept Cardiothorac Surg 13 Yonghan St Dehong;
Kunming Med Univ Affiliated Dehong Peoples Hosp Dept Cardiovasc Med Dehong Yunnan Peoples R;
Kunming Med Univ Affiliated Dehong Peoples Hosp Dept Cardiothorac Surg 13 Yonghan St Dehong;
Kunming Med Univ Affiliated Dehong Peoples Hosp Dept Pathol Dehong Yunnan Peoples R China;
Kunming Med Univ Affiliated Dehong Peoples Hosp Dept Pathol Dehong Yunnan Peoples R China;
Kunming Med Univ Affiliated Dehong Peoples Hosp Dept Cardiothorac Surg 13 Yonghan St Dehong;
机译:用响应Poziotinib的激活EGFR外显子20插入突变成功治疗粟粒转移性NSCLC患者
机译:在患有NSCLC窝藏新EGFR外显子20插入突变的患者中对AFATINIB的反应
机译:患有EGFR突变的NSCLC的患者的成功治疗和伴随的AFATINIB和CRIZOTINIB的伴随符合EXON 14跳过突变
机译:单细胞水平晚期NSCLC患者EGFR激活突变的细胞内异质性
机译:运用统计学习理论评价转移性大肠癌患者的治疗反应和预测结局。
机译:在患有NSCLC窝藏新EGFR外显子20插入突变的患者中对AFATINIB的反应
机译:P1.14-52患者在患有EGFR A763_Y764INSFQEA外显子20插入突变的患者中对Osimertinib的临床反应:案例报告